Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double-blind Controlled Trial to Assess the Benefits of Olanzapine and Amisulpride Combination Treatment in Acutely Ill Schizophrenia Patients. - COMBINE

NCT01609153 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.

NCT NCT01609153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01609153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double-blind Controlled Trial to Assess the Benefits of Olanzapine and Amisulpride Combination Treatment in Acutely Ill Schizophrenia Patients. - COMBINE
Lead sponsor
Heinrich-Heine University, Duesseldorf
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2012
Completion date
April 30, 2019
Enrollment
328 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia